FIVE PRIME THERAPEUTICS

five-prime-therapeutics-logo

FivePrime is dis­cov­er­ing and devel­op­ing novel ther­a­peu­tic pro­teins and anti­bod­ies by sys­tem­at­i­cally screen­ing all rel­e­vant pro­teins in the human body to find the best pro­tein for treat­ment of a given clin­i­cal indi­ca­tion. FivePrime’s Pro­Screen Engine enables the rapid pro­duc­tion and screen­ing of all ther­a­peu­ti­cally rel­e­vant pro­teins in medically-​​focused assays at the high­est qual­ity stan­dards in the indus­try. ... This pow­er­ful approach is the polar oppo­site of the industry’s tra­di­tional “one pro­tein at a time”. The Pro­Screen Engine com­prises the defin­i­tive pro­tein col­lec­tion and screen­ing process for bio­log­ics dis­cov­ery and is unprece­dented in its effi­ciency, qual­ity, and scale. In addi­tion to DBL Investors, investors include Domain Asso­ciates, Ver­sant Ven­tures, Kleiner Perkins Cau­field and Byers, Texas Pacific Group, Health­Cap, and Advanced Tech­nol­ogy Ventures.
#People #Financial #Website #More

FIVE PRIME THERAPEUTICS

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2001-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.fiveprime.com

Total Employee:
101+

Status:
Closed

Contact:
415-365-5600

Email Addresses:
[email protected]

Total Funding:
155.04 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 ReCAPTCHA Microsoft Azure DNS YouTube DoubleClick.Net ReCAPTCHA V2 Microsoft



Current Advisors List

lewis-williams_image

Lewis Williams Chairman of the Board of Directors @ Five Prime Therapeutics
Board_member

bruce-blazar_image

Bruce Blazar Member of the Scientific Advisors @ Five Prime Therapeutics
Advisor

not_available_image

Lee Douglas Member of the Board of Directors @ Five Prime Therapeutics
Board_member
2002-01-01

ronald-levy_image

Ronald Levy Member of the Scientific Advisors @ Five Prime Therapeutics
Advisor

joseph-goldstein_image

Joseph Goldstein Member of the Scientific Advisory Board @ Five Prime Therapeutics
Advisor
2002-07-01

daniel-hoff_image

Daniel Hoff Member of the Scientific Advisors @ Five Prime Therapeutics
Advisor

franklin-berger_image

Franklin Berger Member of the Board of Directors @ Five Prime Therapeutics
Board_member
2010-09-01

kapil-dhingra_image

Kapil Dhingra Member of the Board of Directors @ Five Prime Therapeutics
Board_member
2015-12-01

Current Employees Featured

lauretta-cesario_image

Lauretta Cesario
Lauretta Cesario Vice President, Human Resources @ Five Prime Therapeutics
Vice President, Human Resources
2009-08-01

michael-kavanaugh_image

Michael Kavanaugh
Michael Kavanaugh Senior Vice President and Chief Scientific Officer @ Five Prime Therapeutics
Senior Vice President and Chief Scientific Officer

thomas-civik_image

Thomas Civik
Thomas Civik President & Chief Executive Officer @ Five Prime Therapeutics
President & Chief Executive Officer
2020-04-01

jim-blair_image

Jim Blair
Jim Blair Director @ Five Prime Therapeutics
Director

lewis-williams_image

Lewis Williams
Lewis Williams Founder, President & CEO @ Five Prime Therapeutics
Founder, President & CEO
2011-08-01

kevin-p-baker_image

Kevin P. Baker
Kevin P. Baker Vice President, Preclinical Development @ Five Prime Therapeutics
Vice President, Preclinical Development
2006-01-01

david-v-smith_image

David V. Smith
David V. Smith Executive Vice President & Chief Financial Officer @ Five Prime Therapeutics
Executive Vice President & Chief Financial Officer
2018-11-01

robert-sikorski_image

Robert Sikorski
Robert Sikorski Vice President @ Five Prime Therapeutics
Vice President

Founder


lewis-williams_image

Lewis Williams

Stock Details


Company's stock symbol is NASDAQ:FPRX

Investors List

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Private Equity Round - Five Prime Therapeutics

versant-ventures_image

Versant Ventures

Versant Ventures investment in Private Equity Round - Five Prime Therapeutics

pfizer-venture-investments_image

Pfizer Venture Investments

Pfizer Venture Investments investment in Venture Round - Five Prime Therapeutics

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Venture Round - Five Prime Therapeutics

j-p-morgan-securities-inc_image

J.P. Morgan Securities Inc.

J.P. Morgan Securities Inc. investment in Venture Round - Five Prime Therapeutics

domain-associates_image

Domain Associates

Domain Associates investment in Venture Round - Five Prime Therapeutics

diamond-capital-company_image

Diamond Capital Company

Diamond Capital Company investment in Venture Round - Five Prime Therapeutics

wellcome-trust_image

Wellcome Trust

Wellcome Trust investment in Venture Round - Five Prime Therapeutics

singapore-bio-innovations_image

Singapore Bio-Innovations

Singapore Bio-Innovations investment in Venture Round - Five Prime Therapeutics

advanced-technology-ventures_image

Advanced Technology Ventures

Advanced Technology Ventures investment in Venture Round - Five Prime Therapeutics

Official Site Inspections

http://www.fiveprime.com

  • Host name: ewhserver1302.edgewebhosting.net
  • IP address: 69.63.140.80
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Five Prime Therapeutics" on Search Engine

dfkcompany.com © 2022. All rights reserved